Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Emotional difficulties were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households.

Young child looking out of a window

The most recent report from the Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) study highlights that:

  • Emotional and restless/attention difficulties (and behaviour difficulties for primary school aged children) were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households, with around two and a half times as many children experiencing significant problems in low income households.
  • Parents and carers from low income households reported that their children (aged 4 to 16 years) had higher levels of emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry than those from higher income households. Their children were also more fidgety and restless and had greater difficulty paying attention. Those with younger, primary school aged children also reported that their children were experiencing higher levels of behaviour difficulties, including temper tantrums, arguments and not doing what they were being asked to do by adults than those from higher incomes.

Read more about the report findings on the Department of Experimental Psychology website

The story is also available on the University of Oxford website

Similar stories

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.